CCL2 and esophageal squamous cell carcinoma: Initially, we overexpressed and knocked down CCL2 on the basis of LINC00330 overexpression (Fig. 8A, B, and Additional file 3: Figure S7A&B) and evaluated proliferation, invasion, and EMT of ESCC cells.